title: White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study.
abstract: BACKGROUND
  Elevated white blood cell (WBC) count is associated with risk of venous thromboembolism (VTE) in cancer patients initiating chemotherapy. It is not known whether the risk of VTE by WBC count in cancer patients is causal or merely a consequence of the malignant disease. To address this question, we studied the association between WBC count, measured prior to cancer development, and risk of VTE in subjects who did and did not develop cancer during follow-up in a prospective population-based study.
  
  
  METHODS
  Baseline characteristics, including WBC and neutrophil counts, were measured in 24304 initially cancer-free subjects who participated in the Tromsø Study in 1994-1995. Incident cancer diagnosis and VTE events were registered up to September 1, 2007. In the cancer cohort, WBC and neutrophil counts were measured in average 7.1 years before cancer development. Cox-regression models were used to calculate hazard ratios (HRs) for VTE by WBC and neutrophil counts as categorized variables (<40(th), 40-80(th), and >80(th) percentile) with 95% confidence intervals (CIs).
  
  
  RESULTS
  During follow-up, 1720 subjects developed cancer and there were 388 VTE events, of which 116 occurred in the cancer-group (6.9 per 1000 person-years) and 272 in the cancer-free group (1.1 per 1000 person-years). In those who developed cancer, WBC count above the 80(th) percentile (≥ 8.6 x 10(9) cells/L) was associated with a 2.4-fold higher risk (HR 2.36, 95% CI: 1.44-3.87) of VTE compared to WBC count below the 40(th) percentile (<6.4 x 10(9) cells/L). No association was found between WBC count and VTE in those who stayed cancer-free (HR 0.94, 95% CI 0.65-1.36). Similar findings were observed for neutrophils.
  
  
  CONCLUSIONS
  Pre-cancer WBC count was associated with risk of VTE in cancer patients, but not in cancer-free subjects. Our findings suggest that leukocytes may play a causal role in cancer-related VTE rather than only reflecting the low-grade inflammation associated with cancer.
authors.affiliation: Hematological Research Group, Department of Clinical Medicine, University of Tromsø and Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
authors.forename: Kristine
authors.initials: K
authors.lastname: Blix
authors.forename: Hilde
authors.initials: H
authors.lastname: Jensvoll
authors.forename: Sigrid K
authors.initials: SK
authors.lastname: Brækkan
authors.forename: John-Bjarne
authors.initials: JB
authors.lastname: Hansen
mesh_terms: D063646:Carcinogenesis; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000473:pathology*; D009504:Neutrophils / Q000166:cytology; D012306:Risk; D054556:Venous Thromboembolism / Q000097:blood* / Q000150:complications
references.citation: Am J Med. 2004 Jul 1;117(1):19-25
references.pmid: 15210384
references.citation: Thromb Res. 2010 Jun;125(6):490-3
references.pmid: 20097409
references.citation: N Engl J Med. 2000 Dec 21;343(25):1846-50
references.pmid: 11117976
references.citation: Blood. 2008 Oct 1;112(7):2703-8
references.pmid: 18539899
references.citation: Thromb Res. 2013 Feb;131(2):109-15
references.pmid: 23237339
references.citation: Circ Res. 2011 May 13;108(10):1284-97
references.pmid: 21566224
references.citation: Arch Intern Med. 2000 Mar 27;160(6):809-15
references.pmid: 10737280
references.citation: Thromb Res. 2010 Aug;126(2):113-8
references.pmid: 20684071
references.citation: J Thromb Haemost. 2005 Aug;3(8):1590-6
references.pmid: 16102023
references.citation: Br J Haematol. 2013 Feb;160(4):530-7
references.pmid: 23240761
references.citation: Nature. 2002 Dec 19-26;420(6917):860-7
references.pmid: 12490959
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13835-40
references.pmid: 11095738
references.citation: J Thromb Haemost. 2008 Nov;6(11):1851-7
references.pmid: 18665924
references.citation: Arch Immunol Ther Exp (Warsz). 2006 Mar-Apr;54(2):75-84
references.pmid: 16648968
references.citation: Arch Intern Med. 2006 Jan 23;166(2):188-94
references.pmid: 16432087
references.citation: Thromb Haemost. 2004 Sep;92(3):459-66
references.pmid: 15351841
references.citation: J Thromb Haemost. 2011 Sep;9(9):1791-4
references.pmid: 21718435
references.citation: Nat Med. 2011 Nov 07;17(11):1381-90
references.pmid: 22064428
references.citation: Arch Intern Med. 2004 Aug 9-23;164(15):1653-61
references.pmid: 15302635
references.citation: Chest. 2012 Feb;141(2 Suppl):e195S-e226S
references.pmid: 22315261
references.citation: Thromb Haemost. 2008 Nov;100(5):905-11
references.pmid: 18989537
references.citation: J Clin Oncol. 2011 Sep 1;29(25):3466-73
references.pmid: 21810688
references.citation: Lancet. 1999 Apr 3;353(9159):1167-73
references.pmid: 10209995
references.citation: Br J Cancer. 2010 Sep 28;103(7):947-53
references.pmid: 20842120
references.citation: Br J Cancer. 2007 Oct 8;97(7):978-85
references.pmid: 17912242
references.citation: Eur J Cancer. 2009 May;45(7):1218-1231
references.pmid: 19091545
references.citation: Am J Med. 2002 Dec 1;113(8):636-42
references.pmid: 12505113
references.citation: JAMA. 2005 Feb 9;293(6):715-22
references.pmid: 15701913
references.citation: Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):13076-81
references.pmid: 22826226
references.citation: Am J Epidemiol. 2005 Dec 1;162(11):1062-9
references.pmid: 16221804
references.citation: Blood. 2002 Nov 15;100(10):3484-8
references.pmid: 12393647
references.citation: Eur Heart J. 2004 Jun;25(12):1049-56
references.pmid: 15191776
references.citation: J Thromb Haemost. 2007 Apr;5(4):692-9
references.pmid: 17367492
references.citation: Oncology. 2012;82(6):327-32
references.pmid: 22627488
references.citation: Arch Intern Med. 2007 Sep 24;167(17):1837-44
references.pmid: 17893304
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1052-6
references.pmid: 15184263
references.citation: Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
references.pmid: 20798043